Spain's GMP cannabis operators position for gains as Portugal faces regulatory headwinds

Spanish licensed producers see opportunity as Portugal grapples with traceability gaps, enforcement issues, and market share losses to competitors.

FILE — harvest · My 420 Tours / CC BY-SA 4.0

Spanish good manufacturing practice (GMP) cannabis operators are positioning themselves to capture market share as Portugal's medical cannabis sector faces mounting pressures, according to MMJDaily. Portugal's position in European supply chains has weakened notably—Canadian cannabis flower exports to Portugal have collapsed while Germany now captures 62% of that trade, per Business of Cannabis reporting.

Portugal's vulnerabilities stem from multiple fronts. Infarmed, the national drug authority, faces allegations of regulatory loopholes that enabled a trafficking ring to exploit the system, as Portugal Resident reported in June. Earlier coverage by MMJDaily flagged price pressure and traceability gaps testing the Portuguese medical market, while recent enforcement actions—including zero-tolerance rules on CBD and THC in tobacco products—suggest broader tightening.

Spain, Czechia, and Malta have emerged as alternatives in Europe's cannabis supply chain, per May MMJDaily reporting. Watch whether Spanish GMP operators translate regulatory clarity and operational capacity into concrete export volumes and pricing gains against a retreating Portuguese market.